Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22172502 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
Condition: Influenza
Interventions: Biological: Inactivated seasonal influenza vaccine (split virus, Vero cell-derived);   Biological: Phosphate buffered saline
2 Completed Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older
Condition: Influenza
Interventions: Biological: Vero cell derived, trivalent, seasonal influenza vaccine;   Biological: Licensed egg-derived, trivalent seasonal influenza vaccine

Indicates status has not been verified in more than two years